Pearson plc (PSO)
NYSE: PSO · Real-Time Price · USD
14.50
+0.04 (0.28%)
At close: Aug 11, 2025, 4:00 PM
14.51
+0.01 (0.07%)
After-hours: Aug 11, 2025, 7:00 PM EDT

Ligand Pharmaceuticals Revenue

Pearson had revenue of 1.72B GBP in the half year ending June 30, 2025, a decrease of -8.36%. This brings the company's revenue in the last twelve months to 3.52B, down -0.82% year-over-year. In the year 2024, Pearson had annual revenue of 3.55B, down -3.32%.

Revenue (ttm)
3.52B GBP
Revenue Growth
-0.82%
P/S Ratio
1.95
Revenue / Employee
206,767 GBP
Employees
17,024
Market Cap
9.39B USD

Revenue Chart

* This company reports financials in GBP.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20243.55B-122.00M-3.32%
Dec 31, 20233.67B-167.00M-4.35%
Dec 31, 20223.84B413.00M12.05%
Dec 31, 20213.43B31.00M0.91%
Dec 31, 20203.40B-472.00M-12.20%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.